Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Dare Bioscience, Inc. | dare-20191231xex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Dare Bioscience, Inc. | dare-20191231xex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Dare Bioscience, Inc. | dare-20191231xex311.htm |
| EX-23.1 - EXHIBIT 23.1 - Dare Bioscience, Inc. | dare-20191231xex231.htm |
| EX-21.1 - EXHIBIT 21.1 - Dare Bioscience, Inc. | dare-20191231xex211.htm |
| EX-10.10D - EXHIBIT 10.10D - Dare Bioscience, Inc. | exhibit1010d.htm |
| EX-10.10C - EXHIBIT 10.10C - Dare Bioscience, Inc. | exhibit1010c.htm |
| EX-10.16 - EXHIBIT 10.16 - Dare Bioscience, Inc. | exhibit1016.htm |
| EX-4.6 - EXHIBIT 4.6 - Dare Bioscience, Inc. | exhibit46.htm |
| 10-K - 10-K - Dare Bioscience, Inc. | dare-20191231x10k.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Daré Bioscience, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 27, 2020
/s/ Lisa Walters-Hoffert
Lisa Walters-Hoffert
Chief Financial Officer
(principal financial officer and principal accounting officer)